National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 9858 [2024-02773]

Download as PDF 9858 Federal Register / Vol. 89, No. 29 / Monday, February 12, 2024 / Notices As part of that review, the online survey will be used to: Measure the effect of the 2016–2017 HIPAA Audits on covered entities’ and business associates’ subsequent actions to comply with the HIPAA Rules. Provide entities with an opportunity to give feedback on the Audit and its features, such as the helpfulness of audit-related documents and to respond to audit-related requests; and Seek feedback on the effect of the HIPAA Audit program on the entities’ day-to-day business operations. The information, opinions, and comments collected using the online survey will be used to improve future OCR HIPAA Audits. HHS’ guidance materials and communications, the utility of the online submission portal, whether the Audit helped improve entity compliance, and the entities’ responses to the Audit-report findings and recommendations. Provide OCR with information on the burden imposed on entities to collect ANNUALIZED BURDEN HOUR TABLE Form name OCR HIPAA Audit Participant Survey. OCR HIPAA Audit Participant Survey. Total ........................................... 1 45/60 124.5 41 1 45/60 30.75 ........................................................... 207 ........................ ........................ 155.25 [FR Doc. 2024–02737 Filed 2–9–24; 8:45 am] National Institutes of Health BILLING CODE 4153–01–P National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Maximizing Investigators’ Research Award—E Study Section, March 05, 2024, 8 a.m. to March 6, 2024, 6 p.m., Center for Scientific Review, RKL2, 6701 Rockledge Dr, Bethesda, MD, 20817 which was published in the Federal Register on February 06, 2024, 89 FR 8218, Doc 2024–02265. This meeting is being amended to change the meeting start time from 8 a.m. to 9 a.m. The meeting is closed to the public. Dated: February 6, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–02775 Filed 2–9–24; 8:45 am] BILLING CODE 4140–01–P khammond on DSKJM1Z7X2PROD with NOTICES Total burden hours 166 DEPARTMENT OF HEALTH AND HUMAN SERVICES 21:06 Feb 09, 2024 Average burden per response Covered Entity Privacy and Security Officer(s) or Administrators. Business Associate Privacy and Security Officer(s) or Administrators. Sherrette A. Funn, Paperwork Reduction Act Reports Clearance Officer, Office of the Secretary. VerDate Sep<11>2014 Number of responses per respondent Number of respondents Respondents Jkt 262001 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required). Date: March 8, 2024. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Video Assisted Meeting). Contact Person: Lindsey M. Pujanandez, Ph.D., Scientific Review Officer, Immunology Review Branch, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC 9834, Rockville, MD 20852, (240) 627–3206, lindsey.pujanandez@nih.gov. PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: February 6, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–02773 Filed 2–9–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; URGenT: Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders. Date: February 27, 2024. Time: 10:00 a.m. to 1:00 p.m. E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 89, Number 29 (Monday, February 12, 2024)]
[Notices]
[Page 9858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-02773]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Investigator Initiated Extended 
Clinical Trial (R01 Clinical Trial Required).
    Date: March 8, 2024.
    Time: 12:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20892 (Video Assisted Meeting).
    Contact Person: Lindsey M. Pujanandez, Ph.D., Scientific Review 
Officer, Immunology Review Branch, Scientific Review Program, 
Division of Extramural Activities, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, MSC 9834, Rockville, MD 20852, (240) 627-3206, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 6, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02773 Filed 2-9-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.